Indications
Adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.
Composition
- Active substance
- cenobamate
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Ontozry
- Active substance
- cenobamate
- ATC code
- N03AX
- Group
- Nervous system
- Therapeutic area
- Epilepsy
- Marketing authorisation holder
- Angelini Pharma S.p.A
- Status
- Authorised
- EU authorisation